Inicio › COVID-19 e infecciones por coronavirus › California
Ensayos clínicos de COVID-19 e infecciones por coronavirus en California
12 estudios sobre COVID-19 e infecciones por coronavirus buscan participantes en California.
Ciudades en California
Texto oficial del estudio (inglés)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of California, Los Angeles (UCLA), Los Angeles
- University of California San Francisco, San Francisco
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- y 9 más
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06679140Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 0 a 20 · Todos los sexos · Actualizado el 21 ago 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- UCLA Westwood, Los Angeles
- UCSF Community and Clinical Research Center, San Francisco
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 40 a 64 · Todos los sexos · Actualizado el 18 ago 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
ReclutandoFase 4Se aceptan voluntarios sanos
Edades de 18 a 64 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
- Zuckerberg San Francisco General Hospital (ZSFG), San Francisco
ReclutandoEstudio observacional
Edades de 18 a 100 · Todos los sexos · Actualizado el 23 jul 2026 · NCT04362150Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- City of Hope cancer Center, Duarte
- University of California Davis Health System, Sacramento
ReclutandoFase 3
Todas las edades · Todos los sexos · Actualizado el 23 jun 2026 · NCT03808922Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Stanford University School of Medicine, Stanford
ReclutandoEstudio observacional
Edades de 18 a 99 · Todos los sexos · Actualizado el 27 abr 2026 · NCT04330521Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Stanford University, Palo Alto
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 9 a 64 · Todos los sexos · Actualizado el 18 mar 2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
- Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 5 sept 2025 · NCT05868239De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.